- Record: found
- Abstract: found
- Article: not found
Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population.
J Eugen-Olsen
1 ,
O Andersen ,
A Linneberg ,
S Ladelund ,
T W Hansen ,
A Langkilde ,
J Petersen ,
T Pielak ,
L N Møller ,
J Jeppesen ,
S Lyngbaek ,
M Fenger ,
M H Olsen ,
P R Hildebrandt ,
K Borch-Johnsen ,
T Jørgensen ,
S B Haugaard
Sep 2010
Read this article at
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Low-grade inflammation is thought to contribute to the development of cardiovascular disease (CVD), type-2 diabetes mellitus (T2D), cancer and mortality. Biomarkers of inflammation may aid in risk prediction and enable early intervention and prevention of disease.